Use of a Hypertension Tool to Manage Blood Pressure in Hemodialysis
Overview
The objective of this project is to develop, validate, and implement a tool to help manager hypertension in patients on hemodialysis.
Full Title of Study: “Development, Validation, and Implementation of a Clinical Decision Tool for Blood Pressure Management in Patients on Hemodialysis”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: April 9, 2021
Interventions
- Other: Hypertension tool
- An algorithm developed by staff at UHN to help manage hypertension in hemodialysis patients.
Arms, Groups and Cohorts
- Experimental: Implementation group
- This group will have the hypertension tool implemented on them.
- No Intervention: Control group
- This group will not have the tool implemented.
Clinical Trial Outcome Measures
Primary Measures
- Blood pressure
- Time Frame: 3 months
Participating in This Clinical Trial
Inclusion Criteria
- ≥ 18 years of age – Receiving in-centre HD for at least 3 months – Considered hypertensive based on a median intradialytic blood pressure ≥ 140/90 mmgHG Exclusion Criteria:
- Are unable to provide informed consent – Are deemed medically unstable by the primary physician
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- University Health Network, Toronto
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Marisa Battistella, Principal Investigator, University Health Network, Toronto
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.